MedPath

evothyroxine in Nephrotic syndrome

Phase 3
Conditions
ephrotic Syndrome.
Nephrotic syndrome
Registration Number
IRCT20201112049368N2
Lead Sponsor
Artesh University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
82
Inclusion Criteria

idiopathic nephrotic syndrome
Relapse requiring hospitalization
serum TSH grater than 5.5 mIU/

Exclusion Criteria

congenital nephrotic syndrome
Secondary nephrotic syndrome
GFR less than 60 ml/min/1.73 m2
confirmed hypothyroidism before the diagnosis of nephrotic syndrome

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath